| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.68T | 9.66T | 8.77T | 5.78T | 3.80T | 3.57T |
| Gross Profit | 4.83T | 4.72T | 4.16T | 3.51T | 3.15T | 2.69T |
| EBITDA | 1.95T | 1.98T | 1.64T | 1.37T | 1.17T | 899.42B |
| Net Income | 1.39T | 1.18T | 962.95B | 805.84B | 706.63B | 512.81B |
Balance Sheet | ||||||
| Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Cash, Cash Equivalents and Short-Term Investments | 72.60T | 75.59T | 78.14T | 75.91T | 74.79T | 10.00T> |
| Total Debt | 58.32T | 58.30T | 53.88T | 46.16T | 51.48T | 46.66T |
| Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Stockholders Equity | 15.17T | 14.70T | 14.66T | 12.68T | 12.10T | 11.83T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.60T | 4.72T | -6.19T | 414.72B | 18.47T |
| Operating Cash Flow | 0.00 | 4.97T | 4.86T | -5.90T | 507.31B | 18.80T |
| Investing Cash Flow | 0.00 | -4.51T | -15.80T | 5.93T | -10.73T | -7.68T |
| Financing Cash Flow | 0.00 | -480.15B | 10.52T | -357.78B | 8.88T | -562.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥21.29T | 10.49 | 9.58% | 2.73% | -1.43% | 21.70% | |
71 Outperform | ¥16.74T | 10.71 | 9.14% | 2.38% | -3.62% | 23.01% | |
69 Neutral | ¥3.74T | 10.42 | 10.23% | 3.93% | -2.45% | 35.60% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥31.98T | 13.60 | 9.01% | 2.94% | -1.98% | 6.56% | |
63 Neutral | ¥4.33T | 10.69 | 8.37% | 1.80% | 8.28% | 28.63% | |
63 Neutral | ¥9.75T | 14.35 | 5.28% | 2.73% | 2.17% | 9.55% |